Back to search
FDAFDA · Food and drugs·Recall number Z-1214-2013

NxStage PureFlow-B Solution, Model/Catalog Number: RFP-401, packaged in a case The NxStage PureFLow-B Solution is indicated for use with renal replacement therapy systems that utilize sterile premixed dialysate during hemodialysis.

Published May 8, 2013 · Recall initiated: March 18, 2013

Summary

FDA records medical device Class II recall Z-1214-2013, published May 8, 2013 and initiated March 18, 2013. Recalling firm: NxStage Medical, Inc.; Status: Terminated; Reported quantity: 1480 cases (2 bags per case); Lot: F023444. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Product may be mislabeled.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
NxStage Medical, Inc.
Distributor
Nationwide Distribution including IL, SC, TX, VA, FL, AR, and NY.
Lot
F023444
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was NxStage PureFlow-B Solution, Model/Catalog Number: RFP-401, packaged in a case The NxStage PureFLow-B Solution is indicated for use with renal replacement therapy systems that utilize sterile premixed dialysate during hemodialysis. recalled?

Yes. FDA published recall Z-1214-2013 on May 8, 2013. Reported hazard: Product may be mislabeled.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail